Status:
COMPLETED
Effectiveness of Low Level Laser Therapy on Insulin Resistance and Inflammatory Biomarkers
Lead Sponsor:
Cairo University
Conditions:
Insulin Resistance
Inflammatory Markers
Eligibility:
FEMALE
60-75 years
Phase:
NA
Brief Summary
It is an interventional study in which 60 women estimated to enroll according to random allocation and assigned into two groups equal. The study group will receive active low level laser in addition t...
Detailed Description
PURPOSE: To determine the effectiveness of low level laser therapy on insulin resistance and inflammatory biomarkers in obese postmenopausal breast cancer risk women BACKGROUND: The American Obesit...
Eligibility Criteria
Inclusion
- • Sixty Postmenopausal women (60-75 y)
- Body mass index (BMI) ranged from 30 to 34.9 kg/m2
- Family history of breast cancer
Exclusion
- • women receiving weight-reduction interventions
- taking lipid lowering drugs
- regular medications(e.g., β-blockers, α-blockers, digoxin, diuretics, aspirin, nitrates, or hormones)
- having active chronic illness (e.g., rheumatoid arthritis, hyperthyroidism, and inflammatory bowel disease)
- cognitive impairment that will make it difficult to partake in the study
- presence of malignant disease
- blood donation within the last 30 days
- Participation as a subject in any type of study or research during the prior 90 days
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2023
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04477109
Start Date
July 1 2020
End Date
April 1 2023
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Physical Therapy
Cairo, Egypt, 11432